Table 2. Showing baseline demographics and medical conditions in patients.
| Demographics | ||
| Sample n | 168 | |
| Ruxolitinib group sample size n (%) | 46 (27.4%) | |
| Standard of care group sample size n (%) | 122 (72.6%) | |
| Male n (%) | 88 (52.4%) | |
| Underlying medical conditions n (%) | ||
| Diabetes mellitus (%) | 42 (25%) | |
| Hypertension (%) | 93 (55.4%) | |
| Cardiovascular disease (%) | 42 (25%) | |
| Chronic lung disease (%) | 37 (22.0%) | |
| Current or previous smoker (%) | 33 (19.6%) | |
| Graft-versus-host disease | 2 (1.2%) | |